Patents by Inventor Michelle Haber

Michelle Haber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9387213
    Abstract: Pharmaceutical compositions including a Myc inhibitor are provided. Also provided are methods for treating cancer including administration of compounds that inhibit oncoprotein Myc.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: July 12, 2016
    Assignees: Health Research, Inc., Panacela Labs, Inc., Children's Cancer Institute Australia for Medical Research
    Inventors: Andrei Gudkov, Mikhail Nikiforov, Catherine Burkhart, Michelle Haber, Murray Norris
  • Publication number: 20150272960
    Abstract: Pharmaceutical compositions including a Myc inhibitor are provided. Also provided are methods for treating cancer including administration of compounds that inhibit oncoprotein Myc.
    Type: Application
    Filed: October 14, 2013
    Publication date: October 1, 2015
    Inventors: Andrei Gudkov, Mikhail Nikiforov, Catherine Burkhart, Michelle Haber, Murray Norris
  • Patent number: 8318724
    Abstract: A method of potentiating the activity of a therapeutic drug, like a chemotherapeutic drug or an antibiotic, in a cell or tissue, by inhibiting the efflux capability of a multidrug transporter are disclosed. The method is useful in the treatment of a cancer by sensitizing tumor cells to a chemotherapeutic agent. Compounds capable of inhibiting an efflux capability of a multidrug transporter also are disclosed.
    Type: Grant
    Filed: May 13, 2005
    Date of Patent: November 27, 2012
    Assignees: The Cleveland Clinic Foundation, Children's Cancer Institute Australia for Medical Research
    Inventors: Andrei Gudkov, Michelle Haber, Murray Norris
  • Publication number: 20080032966
    Abstract: A method of potentiating the activity of a therapeutic drug, like a chemotherapeutic drug or an antibiotic, in a cell or tissue, by inhibiting the efflux capability of a multidrug transporter are disclosed. The method is useful in the treatment of a cancer by sensitizing tumor cells to a chemotherapeutic agent. Compounds capable of inhibiting an efflux capability of a multidrug transporter also are disclosed.
    Type: Application
    Filed: May 13, 2005
    Publication date: February 7, 2008
    Applicants: The Cleveland Clinic Foundation, The University of South Wales
    Inventors: Andrei Gudkov, Michelle Haber, Murray Norris